Clinical Trials in Tennessee

Showing 14961-14980 of 20,239 trials

Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Multiple Myeloma and Renal Disease

NCT01949532

The purpose of this study is to see how the body and the cancer react to carfilzomib, including measuring the amount of the study drug in the blood at certain times following dosing. This study is being done in people with normal kidney function and those with end-stage renal disease to see if they respond differently to the study drug.

Relapsed Multiple MyelomaEnd-stage Renal Disease

Amgen26 participantsStarted Jan 2014

Detroit, Michigan, United States • Lake Success, New York, United States • Canton, Ohio, United States +10 more locations

COMPLETEDNA29 miles

Urinary Prostaglandin E Metabolite (PGE-M), A Metabolite of Prostaglandin E2 (PGE2): A Novel Biomarker of Crohn's Disease Activity

NCT00496548

The purpose of this study is to determine whether urinary PGE-M levels correlate with Crohn's disease activity and to compare how well urinary PGE-M correlates with other non-invasive biomarkers of disease activity such as C-reactive protein (CRP) and fecal calprotectin.

Crohn's Disease

Vanderbilt University Medical Center159 participantsStarted Aug 2007

Nashville, Tennessee, United States

Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Multiple Myeloma and Renal Disease

Urinary Prostaglandin E Metabolite (PGE-M), A Metabolite of Prostaglandin E2 (PGE2): A Novel Biomarker of Crohn's Disease Activity

Find Trials by Condition in Tennessee

Phase 1 Study of Oprozomib Administered Orally in Patients With Advanced Refractory or Recurrent Solid Tumors

Discovery Elbow Long-Term Survivorship

Mucosal Impedance in Pediatric Population

Impact of Dietary Intervention on Weight Change in Subjects With Type 2 Diabetes

Safety and Pharmacology Study of SNX-5422 in Subjects With Refractory Hematological Malignancies

PREventative Study Against URate-lowering Drug-induced Gout Exacerbations 1

Characterization of Dermal Reactions in Pediatric Patients With ADHD Using DAYTRANA

Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

Study of the Safety and Effectiveness of Rilonacept for the Prevention of Gout Flares

Phase 2 Study of Carfilzomib in Relapsed Multiple Myeloma

Targeting Acute Congestion With Tolvaptan in Congestive Heart Failure

Inhibitor Development in Patients With Hemophilia A Undergoing Surgery

A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease

Study to Evaluate the Efficacy, Safety and Pharmacokinetics of PT001, PT003, and PT005 Following Chronic Dosing (7 Days) in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Atorvastatin (Lipitor) Therapy in Patients With Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis

Safety and Efficacy Study of DSP-Visulex for the Treatment of Anterior Uveitis

Effect of Squalamine Lactate Ophthalmic Solution, 0.2% in Subjects With Neovascular Age-Related Macular Degeneration

Pulsed Radiofrequency Energy to Treat Post-Bunionectomy Pain